Evidence map›Paper›PMID 17704228›Full record

ArticleJournal of bacteriology2007

The sbcDC locus mediates repression of type 5 capsule production as part of the SOS response in Staphylococcus aureus.

Zhongyi Chen, Thanh T Luong, Chia Y Lee

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. RNAIII of the Staphylococcus aureus agr system activates global regulator MgrA by stabilizing mRNA.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhongyi ChenDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Thanh T Luong
Chia Y Lee
University of Arkansas for Medical Sciences · US

Funding

TYPE 8 CAPSULE OF STAPHYLOCOCCUS AUREUSR01AI037027 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI LEE, CHIA Y. · 1995 to 2013
$3.2M
NIAID NIH HHS AI37027NIAID NIH HHS R01 AI037027
6 · The paper itself

Abstract

Most strains of Staphylococcus aureus produce one type of capsular polysaccharide that belongs to either type 5 or type 8. The production of these capsules has been shown to be regulated by various regulators. Here we report that the sbcD and sbcC genes are involved in the repression of type 5 capsule production. Chromosomal deletions in the sbcDC genes resulted in increased capsule promoter activity, capsule gene transcripts, and capsule production. The survival rates of the sbcDC deletion mutant were reduced upon UV irradiation compared to those for the wild-type strain Newman, suggesting that the genes are involved in DNA repair in S. aureus. The two genes were organized as an operon and were expressed very early in the exponential growth phase. A subinhibitory concentration of ciprofloxacin or mitomycin C induced sbcDC transcription but repressed the capsule promoter activity, suggesting that the sbcDC genes and the capsule genes are part of the SOS regulon. By reporter gene fusion and Northern blotting, we found that sbcDC regulated capsule by downregulating arl and mgr. Further genetic studies indicate that sbcDC functions upstream of arl and mgr in capsule regulation. Collectively, our results indicate that sbcDC, upon the SOS response, represses type 5 capsule production through an arl-mgr pathway. To our knowledge, this is the first demonstration that an SbcDC homolog was involved in transcriptional regulation.

Indexed as

Gene Expression Regulation, BacterialSOS Response, GeneticsAnti-Bacterial AgentsArtificial Gene FusionBacterial CapsulesBacterial Proteinsbeta-GalactosidaseBlotting, NorthernBlotting, WesternCiprofloxacinDeoxyribonucleasesExonucleasesGene DeletionGenes, ReporterMicrobial ViabilityMitomycinAnti-Bacterial AgentsArlR protein, Staphylococcus aureusBacterial Proteinsbeta-GalactosidaseCiprofloxacinDeoxyribonucleasesExonucleasesMitomycinRepressor ProteinsRNA, BacterialRNA, MessengerSbcC protein, Bacteria

Identifiers

PMID17704228
PMCPMC2168426
OpenAlexW2122143698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.